Home | Welcome to Contract Pharma   
Last Updated Saturday, May 25 2013
Print

Financial Reports

Related Searches:

Filter by:

Financial Reports: Covance 2Q11
July 28, 2011
Sanofi sites boost early-stage revenues   Read More »
New Chief Strategy Officer For Sanofi
July 28, 2011
Gros to manage BD, acquisition activities as of September   Read More »
Financial Reports: West 2Q11
July 28, 2011
Currency rates bolster revenue gains   Read More »
Financial Reports: Hospira 2Q11
July 27, 2011
Docetaxel fuels revenue growth   Read More »
Financial Reports: GlaxoSmithKline 2Q11
July 26, 2011
Avandia, Valtrex and pandemic losses reduce revenues   Read More »
Financial Reports: Biogen Idec 2Q11
July 26, 2011
Tysabri revenues climb 28%   Read More »
Financial Report: Roche 1H11
July 21, 2011
Group sales were stable in local currencies, up 2%.   Read More »
Financial Report: Lilly 2Q11
July 21, 2011
Revenue growth helps offset generic competition; restructuring costs hit earnings.   Read More »
Financial Report: Baxter 2Q11
July 21, 2011
BioScience revenues top $1.6 billion, driven by Gammagard demand.   Read More »
Financial Report: Alexion 2Q11
July 21, 2011
Soliris sales jump 48% to $185.7 million.   Read More »
Financial Reports: Icon 2Q11
July 20, 2011
Costs will grow in advance of Pfizer partnership revenues   Read More »
Financial Report: Abbott 2Q
July 20, 2011
Humira sales continue to drive pharma growth   Read More »
Financial Reports: J&J 2Q11
July 19, 2011
Favorable currency changes boost revenues, but earning suffer with Cordis charges   Read More »
Financial Reports: Novartis 2Q11
July 19, 2011
Alcon, new products, generics and currency flux help boost sales   Read More »
Financial Report: Patheon
June 10, 2011
Revenues from commercial manufacturing operations were $138.5 million (-3%) in the quarter.   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: